CAXTON CORP Diversified Active

CIK: 0001388551 · Show all filings

Period: Q2 2015 (← Previous) (Next →)

Filing Date: Aug 14, 2015

Total Value ($000): $94,484 (100.0% shares, 0.0% debt)

Holdings (19)

— SYNTA PHARMACEUTICALS CORP 87.5%

Value ($000) $82,646 Shares 37,061,186 Est. Cost $6.65 Unrealized —

— CELATOR PHARMACEUTICALS INC 5.3%

Value ($000) $5,032 Shares 2,246,469 Est. Cost $3.25 Unrealized —

— MARKET VECTORS ETF TR 1.4%

Value ($000) $1,301 Shares 73,274 Est. Cost $17.76 Unrealized —

— AMERICAN CAP LTD 1.1%

Value ($000) $1,036 Shares 76,434 Est. Cost $14.60 Unrealized —

— ESTERLINE TECHNOLOGIES CORP 0.7%

Value ($000) $628 Shares 6,590 Est. Cost $114.39 Unrealized —

— SENSATA TECHNOLOGIES HLDG NV 0.6%

Value ($000) $572 Shares 10,853 Est. Cost $57.36 Unrealized —

— INVUITY INC 0.5%

Value ($000) $479 Shares 33,905 Est. Cost $14.13 Unrealized —

XPHDX PIONEER FLOATING RATE TR 0.4%

Value ($000) $417 Shares 36,637 Est. Cost $11.60 Unrealized —

— MEDLEY MGMT INC 0.4%

Value ($000) $333 Shares 28,165 Est. Cost $11.00 Unrealized —

— EATON VANCE SR INCOME TR 0.3%

Value ($000) $307 Shares 49,460 Est. Cost $6.40 Unrealized —

— MEDLEY CAP CORP 0.3%

Value ($000) $286 Shares 32,058 Est. Cost $9.17 Unrealized —

— FIFTH STR ASSET MGMT INC 0.3%

Value ($000) $273 Shares 26,562 Est. Cost $10.28 Unrealized —

— TICC CAPITAL CORP 0.2%

Value ($000) $209 Shares 31,142 Est. Cost $6.86 Unrealized —

BRK/B BERKSHIRE HATHAWAY INC DEL 0.2%

Value ($000) $206 Shares 1,511 Est. Cost $142.63 Unrealized 0.0%

— NUVEEN SR INCOME FD 0.2%

Value ($000) $199 Shares 31,142 Est. Cost $6.60 Unrealized —

— AGILE THERAPEUTICS INC 0.2%

Value ($000) $151 Shares 17,559 Est. Cost $8.40 Unrealized —

— BLACKROCK FLOAT RATE OME STR 0.2%

Value ($000) $149 Shares 10,991 Est. Cost $13.87 Unrealized —

— SUNESIS PHARMACEUTICALS INC 0.2%

Value ($000) $144 Shares 47,814 Est. Cost $3.01 Unrealized —

— SYNTA PHARMACEUTICALS CORP 0.1%

Value ($000) $116 Shares 52,000 Est. Cost $6.65 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
—	SYNTA PHARMACEUTICALS CORP	37,061,186	$82,646	87.5%	$6.65	—	COM	87162T206
—	CELATOR PHARMACEUTICALS INC	2,246,469	$5,032	5.3%	$3.25	—	COM	15089R102
—	MARKET VECTORS ETF TR	73,274	$1,301	1.4%	$17.76	—	GOLD MINER ETF	57060U100
—	AMERICAN CAP LTD	76,434	$1,036	1.1%	$14.60	—	COM	02503Y103
—	ESTERLINE TECHNOLOGIES CORP	6,590	$628	0.7%	$114.39	—	COM	297425100
—	SENSATA TECHNOLOGIES HLDG NV	10,853	$572	0.6%	$57.36	—	SHS	N7902X106
—	INVUITY INC	33,905	$479	0.5%	$14.13	—	COM NEW	46187J205
XPHDX	PIONEER FLOATING RATE TR	36,637	$417	0.4%	$11.60	—	COM	72369J102
—	MEDLEY MGMT INC	28,165	$333	0.4%	$11.00	—	CL A COM	58503T106
—	EATON VANCE SR INCOME TR	49,460	$307	0.3%	$6.40	—	SH BEN INT	27826S103
—	MEDLEY CAP CORP	32,058	$286	0.3%	$9.17	—	COM	58503F106
—	FIFTH STR ASSET MGMT INC	26,562	$273	0.3%	$10.28	—	CL A COM	31679P109
—	TICC CAPITAL CORP	31,142	$209	0.2%	$6.86	—	COM	87244T109
BRK/B	BERKSHIRE HATHAWAY INC DEL	1,511	$206	0.2%	$142.63	0.0%	CL B NEW	084670702
—	NUVEEN SR INCOME FD	31,142	$199	0.2%	$6.60	—	COM	67067Y104
—	AGILE THERAPEUTICS INC	17,559	$151	0.2%	$8.40	—	COM	00847L100
—	BLACKROCK FLOAT RATE OME STR	10,991	$149	0.2%	$13.87	—	COM	09255X100
—	SUNESIS PHARMACEUTICALS INC	47,814	$144	0.2%	$3.01	—	COM NEW	867328601
—	SYNTA PHARMACEUTICALS CORP	52,000	$116	0.1%	$6.65	—	Call	87162T206